ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,770, issued on July 22, was assigned to Multitude Inc. (Shanghai).
"Antibodies specific to MUC18" was invented by Bing Hou (Shanghai), Guangcun Cheng (Shanghai), Shaofei Zhang (Shanghai), Na Wang (Shanghai), Shu-Hui Liu (Redwood City, Calif.) and Xun Meng (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "Antibodies specific to MUC18 (a.k.a. MCAM or CD146) and antibody-drug conjugates (ADCs) comprising such. Also provided herein are uses the the anti-MUC18 antibodies or ADCs for therapeutic and diagnostic purposes."
The patent was filed on June 17, 2021, under Application No. 17/351,014.
*For further information, including images, charts and...